公司资料
Cardiol Therapeutics Inc 股价、新闻与催化剂
- 股票代码:
- CRDL
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Canada and listed in the U
股票表现
1.80 USD (0.00%)
收盘价
最后更新: 2026年8月17日
133M USD
市值
股价为何变动
As of Aug 17, 2026, CRDL was little changed and closed at $1.80. No new same-company headline was identified in the current news window.
公司概览
业务概览
Cardiol Therapeutics is a biotechnology company focused on inflammatory heart disease and cardiology-related immunology. Its story centers on whether anti-inflammatory approaches can improve cardiac outcomes in a focused setting.
所在地与行业分类
Cardiol Therapeutics is headquartered in Canada and listed in the U.S. market. It sits in specialty cardiology biotechnology.
商业模式特征
The company depends on clinical data, translational confidence, and the ability to keep a narrow cardiovascular pipeline moving. Investors watch efficacy, safety, and proof-of-concept work.
生物医药行业定位
Cardiol occupies a specialized cardio-immunology niche within biotech. The stock is catalyst-sensitive because the market needs evidence that the platform can matter in cardiac disease.
未来催化剂
- CRDL is a small-cap biotech / diagnostics name with catalysts around product and pipeline updates, plus any strategic step that clarifies the company's direction. The market will care about whether there is still a viable growth path.
近期新闻
- 01
- 02
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。